Scandion Oncology - Annual Report 2021
Scandion Oncology (Scandion) today announces that the Annual Report 2021 is available on the company’s website. For further information please contact: Mads Kronborg, Head of External Communication Phone: +45 6051 4955 E-mail: ir@scandiononcology.com (info@scandiononcology.com) The information was provided by the contact person above for publication on March 24, 2022, at 08.30 CET. Scandion Oncology A/S, the Cancer Drug Resistance Company, is a clinical phase II biotechnology company currently developing first-in-class, oral add-on drugs to existing market leading anti-